Purpose: Hashimoto’s thyroiditis (HT) is a significant public health concern, particularly among females. While existing studies have explored the correlation between serum iron levels and HT, limited research has specifically focused on this association in reproductive-age females. Our study aims to investigate the relationship between serum iron and HT.Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) database (2007–2012), we employed weighted multivariate logistic regression models, an XGBoost model, and smooth curve fitting. We assessed the correlation between serum iron and HT and examined linear and non-linear relationships with thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb).Results: Among 2,356 participants, each unit increase in serum iron was associated with a 43% reduced risk of HT (Odds Ratios (OR) 0.574; 95% Confidence Interval (CI) 0.572, 0.576). Quartile analysis confirmed these effects. The XGBoost model identified serum iron as the most significant variable correlated with HT. Smooth curves revealed a linear association between log2-transformed serum iron and HT. Additionally, log2-transformed serum iron inversely correlated with TPOAb levels (β −15.47; 95% CI -25.01, −5.92), while a non-linear relationship was observed with TgAb.Conclusion: Our study reveals that in reproductive-age women, every unit increase in serum iron is associated with a 43% lower risk of HT, demonstrating an inverse relationship. Additionally, serum iron exhibits a negative correlation with TPOAb and a non-linear association with TgAb.
This study evaluates the relationship between dietary iron intake and all-cause mortality in elderly individuals with autoimmune thyroiditis (AT). Data from the National Health and Nutrition Examination Survey (2007–2012) included 2578 participants aged ≥60 years, of whom 464 had AT. Dietary iron intake was assessed by two 24-hour recalls and categorized into tertiles. Mortality data came from the National Death Index. Associations were examined using Cox regression and restricted cubic splines, adjusting for demographics, lifestyle, and clinical factors. Higher dietary iron intake was inversely associated with mortality in elderly AT patients. Each 1-log2 increase in iron intake reduced mortality risk by 24% (hazard ratio = 0.762; 95% confidence interval = 0.633–0.918; P = .004). Adjusted hazard ratios for the second and third tertiles were 0.671 and 0.522, respectively. No significant association was found in participants without AT ( P = .057). A nonlinear threshold effect was observed ( P = .002), with a cutoff of 13.2 mg/day – above which no additional mortality benefit was seen. Sufficient dietary iron intake lowers all‑cause mortality risk in elderly AT patients, following a nonlinear pattern with a threshold around 13.2 mg/day. This association was not significant in individuals without AT.